Having identified the palmitoylation motif of APLNR, we built a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web-site in combination with morphine, can inhibit the event of NCP, together with pain incidence, microglial activation, and inflammatory factor https://jaidenmomjm.p2blogs.com/26402889/everything-about-block-pain-receptors-with-proleviate